Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints

L H Vandenberghe1, E Breous, H-J Nam

  • 1Gene Therapy Program, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Gene Therapy
|September 4, 2009
PubMed
Summary

Novel adeno-associated virus (AAV) vectors were engineered by analyzing capsid structure. Modifications to specific amino acids improved vector manufacturing and gene transfer efficiency for diverse therapeutic applications.